In peptide therapy, one plus one often equals more than two. Certain peptides work synergistically because they hit the growth hormone axis from different angles. Tesamorelin and ipamorelin are one of the cleanest examples of that principle in modern clinical use.
This stack pairs the most metabolically targeted GHRH analog with the cleanest GHRP available. The result is a stronger, more efficient growth hormone response with a very favorable side-effect profile.
Two Peptides, Two Roles
Tesamorelin acts as a GHRH analog: it tells the pituitary to produce more growth hormone and it does so with a particular affinity for driving visceral fat loss. Ipamorelin acts as a GHRP: it amplifies each release pulse and reduces the natural somatostatin feedback that limits how much GH your body will let out.
Used together, the amplitude of each pulse is larger and the number of usable pulses per day is greater — without pushing the pituitary in a way that shuts down long-term function.
Why Ipamorelin Is the Right Partner
Older GHRPs like GHRP-6 or hexarelin work, but they also stimulate cortisol, prolactin, and hunger. That is exactly what most adult patients do not want.
Ipamorelin is selective. It amplifies growth hormone release without meaningfully touching cortisol or prolactin. Combined with tesamorelin's targeted metabolic profile, the stack is unusually well-tolerated for how strong the results are.
What the Stack Feels Like
Improved sleep depth is usually the first noticeable change, often within the first few weeks. Recovery from training and physical work improves in a similar window. Around month two, body composition changes become visible — often centered on the midsection where visceral fat sits.
By month three or four, most patients report better skin quality, more stable energy, and improved workout capacity. The changes are not dramatic overnight, which is exactly why they hold.
Dosing and Cycles
Typical protocols use 1 to 2 mg of tesamorelin plus 200 to 300 mcg of ipamorelin daily, given as a single subcutaneous injection at bedtime. Cycles run 12 to 20 weeks with monitoring of IGF-1, glucose, and body composition.
Summit uses combined compounded formulations where appropriate, which simplifies dosing and reduces injection burden. Every cycle is bookended by lab work to make sure the response is where it should be.
Who Should Consider the Stack
The tesamorelin + ipamorelin stack is a strong fit for adults over 35 with persistent visceral fat, patients with metabolic dysfunction who also want recovery and sleep benefits, and high-performers who want a growth hormone protocol with a clean side-effect profile.
It is not for anyone with active cancer, uncontrolled endocrine disease, or during pregnancy. As always, medical screening comes first.
Build a Stack That Actually Fits You
Talk to a Summit clinician about combining peptides safely and effectively.
Start Your Consultation